Additionally, higher expression of EZH2 mRNA was confirmed in HNSCC patients and is correlated with overexpression of DNMT3A, as well as with stage of cancer and recurrence, which suggests a role of EZH2 in tumor progression (Mochizuki et al. 2018). This evidence concerns the gene EZH2 and neoplasm.